KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutrien (NTR) Receivables - Other (2017 - 2024)

Historic Receivables - Other for Nutrien (NTR) over the last 8 years, with Q4 2024 value amounting to $271.0 million.

  • Nutrien's Receivables - Other rose 1434.6% to $271.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $271.0 million, marking a year-over-year increase of 1434.6%. This contributed to the annual value of $271.0 million for FY2024, which is 1434.6% up from last year.
  • According to the latest figures from Q4 2024, Nutrien's Receivables - Other is $271.0 million, which was up 1434.6% from $237.0 million recorded in Q4 2023.
  • In the past 5 years, Nutrien's Receivables - Other ranged from a high of $282.0 million in Q4 2022 and a low of -$48.0 million during Q1 2023
  • Moreover, its 5-year median value for Receivables - Other was $252.5 million (2020), whereas its average is $204.3 million.
  • In the last 5 years, Nutrien's Receivables - Other surged by 3333.33% in 2020 and then plummeted by 1940.3% in 2021.
  • Over the past 5 years, Nutrien's Receivables - Other (Quarter) stood at $268.0 million in 2020, then dropped by 19.4% to $216.0 million in 2021, then soared by 30.56% to $282.0 million in 2022, then decreased by 15.96% to $237.0 million in 2023, then grew by 14.35% to $271.0 million in 2024.
  • Its Receivables - Other stands at $271.0 million for Q4 2024, versus $237.0 million for Q4 2023 and -$48.0 million for Q1 2023.